title: Reporting of medication regimen in applied studies of persons with mental retardation and ADHD.
abstract: The present survey determined whether articles describing attempts to alter behavior in people with mental retardation and Attention-Deficit/Hyperactivity Disorder (ADHD) (a) reported whether or not participants were receiving medications, (b) evaluated drugs as independent variables, and (c) evaluated (or discussed) interactions between pharmacological and nonpharmacological treatments. All behavior-change articles published from 1991 through 1995 in 10 major journals were evaluated. In contrast to the results of earlier surveys, nearly 40% of studies involving participants with mental retardation provided information about medication. This change appears to represent a significant methodological improvement. Nearly 60% of articles involving persons with ADHD provided information about medication. Studies of drugs were common when participants were people with ADHD, but not when they were people with mental retardation. The psychopharmacology of mental retardation continues to be a small, but important, research area. Studies examining treatment interactions were rare, regardless of participants' characteristics. Given that pharmacological treatments may alter participants' sensitivity to nonpharmacological interventions, further research in this area is sorely needed.
authors.affiliation: Department of Psychology, Western Michigan University, Kalamazoo 49008, USA.
authors.forename: L
authors.initials: L
authors.lastname: Christian
authors.forename: C L
authors.initials: CL
authors.lastname: Kerr
authors.forename: G E
authors.initials: GE
authors.lastname: Sutphin
authors.forename: A
authors.initials: A
authors.lastname: Poling
mesh_terms: D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D004282:Documentation / Q000379:methods; D004347:Drug Interactions; D006801:Humans; D008607:Intellectual Disability / Q000188:drug therapy*; D010506:Periodicals as Topic; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D011643:Publishing; D012106:Research; D012919:Social Behavior; D016896:Treatment Outcome
chemical_list: D011619:Psychotropic Drugs